Otsuka Group News

Keyword search

Search by company	Otsuka Holdings Otsuka Pharmaceutical Otsuka Pharmaceutical Factory Taiho Pharmaceutical Otsuka Warehouse Otsuka Chemical Otsuka Foods Otsuka Medical Devices Other
Search by category^*	Pharmaceuticals Business Nutraceuticals Business Consumer Products Business Others Products R&D Personnel Corporate * Business categories are based on the business segments described in the financial announcements.
Search by release date	-

March 11, 2019
Taiho Pharmaceutical

Taiho Pharmaceutical Announces Personnel Changes
March 11, 2019
Otsuka Pharmaceutical

Notice regarding the conclusion of co-development/co-promotion activities in Japan for the anti-epileptic drug "E Keppra"
March 7, 2019
Otsuka Pharmaceutical

Otsuka Pharmaceutical Reappointments and New Appointments of Board Members and Statutory Auditors
March 5, 2019
Otsuka Pharmaceutical

Selincro Tablets 10mg Launched in Japan
February 27, 2019
Otsuka Pharmaceutical

Refreshing Men's Facial Lotion for Summer Comfort Introducing UL·OS Medicated Skin Breezy Lotion A single product to moisturize, minimize oily shine, and prevent formation of blemishes
February 26, 2019
Taiho Pharmaceutical

FDA Approves LONSURF® (trifluridine/tipiracil) for Adult Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
February 19, 2019
Otsuka Pharmaceutical

Otsuka Pharmaceutical to Serve as an Official Partner for Tokyo Marathon 2019 New "Run," "Support," "Boost," Program Benefits All Participants
February 15, 2019
Otsuka Holdings Otsuka Pharmaceutical

Otsuka and Lundbeck report phase III data evaluating brexpiprazole for the treatment of manic episodes associated with bipolar I disorder
February 15, 2019
Otsuka Pharmaceutical

Otsuka and Lundbeck report phase III data evaluating brexpiprazole for the treatment of manic episodes associated with bipolar I disorder
February 14, 2019
Otsuka Pharmaceutical

Designation Description Change of NY-ESO-1・siTCRTM gene therapy product under "SAKIGAKE Designation System"
February 13, 2019
Otsuka Holdings

Otsuka Holdings Announces Personnel Changes
February 13, 2019
Otsuka Holdings

Notice of Introduction of Restricted Stock Compensation Plan
February 13, 2019
Otsuka Pharmaceutical

Avanir Pharmaceuticals, Inc. Reaches Agreement in Principle with U.S. Department of Justice Regarding NUEDEXTA (dextromethorphan HBr and quinidine sulfate) 20 mg/10 mg capsule
February 5, 2019
Taiho Pharmaceutical

Taiho Pharmaceutical and Cullinan Oncology Establish Collaboration to Develop TAS6417, Novel EGFR Tyrosine Kinase Inhibitor
February 4, 2019
Otsuka Pharmaceutical

Introducing SOYJOY Crispy Sakura Special Seasonal Flavor from SOYJOY Brand of Whole Soy Nutrition Bars
January 8, 2019
Otsuka Pharmaceutical

Selincro (nalmefene) Tablets 10mg Receives Regulatory Approval in Japan
January 4, 2019
Otsuka Pharmaceutical

Otsuka and Click Therapeutics Collaborate to Develop and Commercialize Digital Therapeutics for Patients with Major Depressive Disorder